6-18122295-A-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_198586.3(NHLRC1):ā€‹c.312T>Cā€‹(p.His104His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0956 in 1,593,860 control chromosomes in the GnomAD database, including 8,055 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.11 ( 1232 hom., cov: 33)
Exomes š‘“: 0.094 ( 6823 hom. )

Consequence

NHLRC1
NM_198586.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.631
Variant links:
Genes affected
NHLRC1 (HGNC:21576): (NHL repeat containing E3 ubiquitin protein ligase 1) The protein encoded by this gene is a single subunit E3 ubiquitin ligase. Laforin is polyubiquitinated by the encoded protein. Defects in this intronless gene lead to an accumulation of laforin and onset of Lafora disease, also known as progressive myoclonic epilepsy type 2 (EPM2).[provided by RefSeq, Mar 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 6-18122295-A-G is Benign according to our data. Variant chr6-18122295-A-G is described in ClinVar as [Benign]. Clinvar id is 129766.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-18122295-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.191 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NHLRC1NM_198586.3 linkuse as main transcriptc.312T>C p.His104His synonymous_variant 1/1 ENST00000340650.6 NP_940988.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NHLRC1ENST00000340650.6 linkuse as main transcriptc.312T>C p.His104His synonymous_variant 1/16 NM_198586.3 ENSP00000345464.3 Q6VVB1

Frequencies

GnomAD3 genomes
AF:
0.115
AC:
17446
AN:
152110
Hom.:
1230
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.195
Gnomad AMI
AF:
0.0628
Gnomad AMR
AF:
0.0983
Gnomad ASJ
AF:
0.0775
Gnomad EAS
AF:
0.0142
Gnomad SAS
AF:
0.0816
Gnomad FIN
AF:
0.0607
Gnomad MID
AF:
0.117
Gnomad NFE
AF:
0.0906
Gnomad OTH
AF:
0.117
GnomAD3 exomes
AF:
0.0861
AC:
18216
AN:
211654
Hom.:
923
AF XY:
0.0843
AC XY:
9899
AN XY:
117380
show subpopulations
Gnomad AFR exome
AF:
0.199
Gnomad AMR exome
AF:
0.0820
Gnomad ASJ exome
AF:
0.0738
Gnomad EAS exome
AF:
0.0143
Gnomad SAS exome
AF:
0.0807
Gnomad FIN exome
AF:
0.0721
Gnomad NFE exome
AF:
0.0895
Gnomad OTH exome
AF:
0.0906
GnomAD4 exome
AF:
0.0936
AC:
134892
AN:
1441632
Hom.:
6823
Cov.:
36
AF XY:
0.0923
AC XY:
66167
AN XY:
716930
show subpopulations
Gnomad4 AFR exome
AF:
0.202
Gnomad4 AMR exome
AF:
0.0840
Gnomad4 ASJ exome
AF:
0.0773
Gnomad4 EAS exome
AF:
0.0131
Gnomad4 SAS exome
AF:
0.0791
Gnomad4 FIN exome
AF:
0.0742
Gnomad4 NFE exome
AF:
0.0959
Gnomad4 OTH exome
AF:
0.0913
GnomAD4 genome
AF:
0.115
AC:
17460
AN:
152228
Hom.:
1232
Cov.:
33
AF XY:
0.111
AC XY:
8300
AN XY:
74444
show subpopulations
Gnomad4 AFR
AF:
0.195
Gnomad4 AMR
AF:
0.0981
Gnomad4 ASJ
AF:
0.0775
Gnomad4 EAS
AF:
0.0142
Gnomad4 SAS
AF:
0.0810
Gnomad4 FIN
AF:
0.0607
Gnomad4 NFE
AF:
0.0906
Gnomad4 OTH
AF:
0.115
Alfa
AF:
0.0850
Hom.:
533
Bravo
AF:
0.121
Asia WGS
AF:
0.0660
AC:
230
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)May 18, 2016- -
Lafora disease Benign:3
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsApr 28, 2017- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
not provided Benign:2
Benign, no assertion criteria providedclinical testingMayo Clinic Laboratories, Mayo ClinicDec 16, 2015- -
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsMar 18, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
3.6
DANN
Benign
0.45

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs115931931; hg19: chr6-18122526; COSMIC: COSV61481531; API